Feng, Lili,Gong, Baoqing,Karpinski, Piotr H.,Waykole, Liladhar Murlidhar
申请号:
HRP20181737
公开号:
HRP20181737T1
申请日:
2018.10.22
申请国别(地区):
HR
年份:
2018
代理人:
摘要:
The present invention describes crystalline form of 5-chloro-N-(2-isopropoxy-5-methyl-4-(piperidin-4-ylphenyl)-N-2-(isopropylsulfonyl)phenyl)-2,4-diamine. The present invention further relates to pharmaceutical compositions comprising said crystalline form, and methods of using said crystalline form and pharmaceutical composition to treat disease.